Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19212338

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2009 Jun
First author
Van der Velden VH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Van der Velden VH
      type
      Author
    2. name
      Corral L
      type
      Author
    3. name
      Valsecchi MG
      type
      Author
    4. name
      Jansen MW
      type
      Author
    5. name
      De Lorenzo P
      type
      Author
    6. name
      Cazzaniga G
      type
      Author
    7. name
      Panzer-Grümayer ER
      type
      Author
    8. name
      Schrappe M
      type
      Author
    9. name
      Schrauder A
      type
      Author
    10. name
      Meyer C
      type
      Author
    11. name
      Marschalek R
      type
      Author
    12. name
      Nigro LL
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Van der Velden VH
      type
      Author
    2. name
      Corral L
      type
      Author
    3. name
      Valsecchi MG
      type
      Author
    4. name
      Jansen MW
      type
      Author
    5. name
      De Lorenzo P
      type
      Author
    6. name
      Cazzaniga G
      type
      Author
    7. name
      Panzer-Grümayer ER
      type
      Author
    8. name
      Schrappe M
      type
      Author
    9. name
      Schrauder A
      type
      Author
    10. name
      Meyer C
      type
      Author
    11. name
      Marschalek R
      type
      Author
    12. name
      Nigro LL
      type
      Author
    bibliography ids
    1. nci-bib-879f63297e16cadb87d87170
    book metadata
    content sha256
    0cf0948aacda820c01b0bcaef8225ea4eeada6cc5d274958f38cda69a8917fa3
    document type
    citation
    dois
    1. 10.1038/leu.2009.17
    electronic publication date
    display
    2009 Feb 12
    precision
    day
    year
    2009
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:19212338
    immutable id
    pubmed:19212338@0cf0948aacda820c01b0bcaef8225ea4eeada6cc5d274958f38cda69a8917fa3
    journal
    abbreviation
    Leukemia
    issn electronic
    1476-5551
    issn print
    0887-6924
    issue
    6
    name
    Leukemia
    nlm unique id
    8704895
    pages
    1073-9
    volume
    23
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      19212338
      provenance
      batch id
      27a383f06e5fc3d04fad
      provider
      NCBI PubMed ESummary
      record sha256
      5a87f502b5bf36a5bd6bbb2b0799c457c2267b652618936dc1d98af17e33fc0f
      response sha256
      51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
      retrieved at
      2026-09-09T23:46:24.265787+00:00
      publication date
      display
      2009 Jun
      precision
      month
      year
      2009
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/19212338/
      title
      Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.

      Preserved source evidence · Not medical advice